Suven Life Sciences Ltd

Suven Life Scie. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Suven Life Sciences Ltd

₹ 94.8 -1.66%
30 May - close price
suven.com BSE: 530239 NSE: SUVEN
About

Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders.[1]

Key Points

Primary Focus
The company has been working towards developing new molecules/ compounds in the complex CNS (central nervous system) space. [1]
Most of its lead molecules address the niche areas of cognitive impairments such as amnesia, dementia, narcolepsy, Alzheimer's, delirium, etc. [2]
CNS is the 2nd largest therapeutic category in the pharmaceutical industry and is also one of the fastest growing segments. [3]

Website BSE NSE
  • Market Cap ₹ 2,068 Cr.
  • Current Price ₹ 94.8
  • High / Low ₹ 129 / 57.2
  • Stock P/E
  • Book Value ₹ 38.8
  • Dividend Yield 0.00 %
  • ROCE -1.92 %
  • ROE -1.82 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -47.2% over past five years.
  • Company has a low return on equity of -4.32% over last 3 years.
  • Company's cost of borrowing seems high
  • Working capital days have increased from 1,190 days to 2,768 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
1.56 2.01 1.18 4.43 4.22 3.54 4.39 3.00 2.61 3.80 3.06 2.45 2.39
10.10 13.88 11.48 11.44 11.69 10.61 11.84 10.10 8.74 10.60 11.14 11.65 9.26
Operating Profit -8.54 -11.87 -10.30 -7.01 -7.47 -7.07 -7.45 -7.10 -6.13 -6.80 -8.08 -9.20 -6.87
OPM % -547.44% -590.55% -872.88% -158.24% -177.01% -199.72% -169.70% -236.67% -234.87% -178.95% -264.05% -375.51% -287.45%
1.32 4.56 0.50 0.14 0.12 6.44 0.21 2.20 5.60 5.64 12.60 6.07 4.28
Interest 0.18 0.15 0.15 0.13 0.10 0.10 0.07 0.06 0.05 0.05 0.04 0.04 0.03
Depreciation 1.07 1.03 1.03 1.22 1.10 1.58 1.62 1.67 1.67 1.66 1.73 1.60 1.51
Profit before tax -8.47 -8.49 -10.98 -8.22 -8.55 -2.31 -8.93 -6.63 -2.25 -2.87 2.75 -4.77 -4.13
Tax % -0.59% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 24.21%
-8.51 -8.49 -10.98 -8.22 -8.55 -2.31 -8.93 -6.63 -2.25 -2.87 2.76 -4.77 -3.12
EPS in Rs -0.45 -0.44 -0.58 -0.43 -0.39 -0.11 -0.41 -0.30 -0.10 -0.13 0.13 -0.22 -0.14
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
257.74 510.29 520.86 499.27 543.23 625.20 285.67 12.62 13.48 11.84 13.54 11.69
204.55 291.23 361.40 369.38 377.88 392.28 236.98 47.89 43.93 48.30 41.05 42.63
Operating Profit 53.19 219.06 159.46 129.89 165.35 232.92 48.69 -35.27 -30.45 -36.46 -27.51 -30.94
OPM % 20.64% 42.93% 30.61% 26.02% 30.44% 37.26% 17.04% -279.48% -225.89% -307.94% -203.18% -264.67%
1.04 3.03 8.58 19.29 21.09 23.27 27.25 14.04 7.75 5.24 14.45 28.59
Interest 13.51 10.51 4.71 5.87 5.67 4.61 1.90 0.54 0.91 0.64 0.52 0.16
Depreciation 7.87 8.84 11.78 17.50 21.41 21.31 10.79 4.17 4.35 4.39 6.54 6.50
Profit before tax 32.85 202.74 151.55 125.81 159.36 230.27 63.25 -25.94 -27.96 -36.25 -20.12 -9.01
Tax % 6.12% 28.89% 28.25% 20.45% 22.52% 31.20% 38.04% 46.95% 19.03% 0.00% 0.00% 11.10%
30.84 144.16 108.75 100.08 123.47 158.43 39.19 -13.75 -22.63 -36.25 -20.13 -8.01
EPS in Rs 1.76 8.23 5.70 5.24 6.47 8.30 2.05 -0.72 -1.19 -1.66 -0.92 -0.37
Dividend Payout % 11.36% 20.26% 7.02% 25.44% 10.31% 12.05% 48.72% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -31%
5 Years: -47%
3 Years: -5%
TTM: -14%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 10%
TTM: 45%
Stock Price CAGR
10 Years: 33%
5 Years: 41%
3 Years: 4%
1 Year: 63%
Return on Equity
10 Years: 6%
5 Years: -4%
3 Years: -4%
Last Year: -2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 11.68 11.68 12.73 12.73 12.73 12.73 12.73 12.73 12.73 14.54 21.81 21.81
Reserves 142.78 252.76 546.59 610.74 718.80 853.97 388.99 374.95 352.01 461.44 831.64 823.57
117.07 90.57 108.51 82.55 70.79 33.99 2.72 6.01 4.76 3.21 1.61 0.71
56.09 131.62 105.30 67.75 73.85 113.79 35.04 16.07 45.88 7.17 5.38 5.39
Total Liabilities 327.62 486.63 773.13 773.77 876.17 1,014.48 439.48 409.76 415.38 486.36 860.44 851.48
161.52 179.23 171.95 305.35 305.72 307.73 22.35 24.69 20.96 37.56 37.21 28.21
CWIP 4.15 12.82 107.01 7.20 9.72 24.74 0.02 0.00 4.77 3.55 0.00 0.00
Investments 0.07 0.04 0.04 23.10 365.97 381.02 359.29 241.86 295.11 425.85 528.20 653.05
161.88 294.54 494.13 438.12 194.76 300.99 57.82 143.21 94.54 19.40 295.03 170.22
Total Assets 327.62 486.63 773.13 773.77 876.17 1,014.48 439.48 409.76 415.38 486.36 860.44 851.48

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
30.69 121.18 142.91 89.82 147.27 104.77 -12.01 -45.15 -36.68 -36.62 -10.09 12.29
-14.66 -35.53 -110.45 -61.65 -352.61 -37.81 -3.52 42.03 2.41 -107.46 -361.66 -33.53
2.55 -38.23 179.13 -68.06 -30.37 -52.05 4.55 3.81 34.86 145.69 395.54 -1.05
Net Cash Flow 18.58 47.42 211.59 -39.90 -235.71 14.92 -10.98 0.69 0.58 1.61 23.79 -22.30

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 33.68 46.83 28.15 39.16 30.79 35.93 3.37 65.65 47.66 40.08 21.84 40.28
Inventory Days 237.58 210.23 165.22 183.07 222.37 328.51 0.00
Days Payable 159.56 109.35 88.64 78.09 91.20 133.84
Cash Conversion Cycle 111.69 147.70 104.73 144.14 161.96 230.61 3.37 65.65 47.66 40.08 21.84 40.28
Working Capital Days 50.13 61.51 68.74 77.24 65.60 102.52 56.33 1,210.98 1,320.28 331.09 470.40 2,767.63
ROCE % 18.66% 68.07% 30.53% 16.85% 19.22% 25.45% 6.80% -6.49% -7.10% -9.33% -4.11%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
60.00% 60.00% 60.00% 64.98% 64.98% 64.98% 69.56% 69.56% 69.56% 69.56% 69.56% 69.56%
0.41% 0.44% 0.52% 0.45% 0.45% 0.48% 0.46% 0.51% 0.48% 0.50% 0.54% 0.46%
0.44% 0.44% 0.44% 0.46% 0.39% 0.12% 0.11% 0.11% 0.08% 0.01% 0.01% 1.05%
39.15% 39.12% 39.04% 34.11% 34.18% 34.41% 29.85% 29.80% 29.88% 29.92% 29.88% 28.91%
No. of Shareholders 86,00881,47580,19581,03981,03880,11680,83878,63476,29180,95374,00368,959

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls